Michael E. Williams

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Simon Rule, Peter Martin et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results

Michael Wang, Kristie A. Blum, Peter Martin et al. · Blood · 2015 · 396 citations · Full text

Rituximab Infusion Promotes Rapid Complement Depletion and Acute CD20 Loss in Chronic Lymphocytic Leukemia

Adam D. Kennedy, Paul V. Beum, Michael D. Solga et al. · The Journal of Immunology · 2004 · 351 citations · Full text

P2 Purinergic Receptors: Modulation of Cell Function and Therapeutic Potential

Geoffrey Burnstock, Michael E. Williams · Journal of Pharmacology and Experimental Therapeutics · 2000 · 275 citations

Postibrutinib outcomes in patients with mantle cell lymphoma

Peter Martin, Kami J. Maddocks, John P. Leonard et al. · Blood · 2016 · 275 citations · Full text